|
The regulator’s perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future? |
|
|
|
Title: |
The regulator’s perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future? |
Author: |
Comi, Giancarlo Crommelin, Daan JA Broich, Karl Holloway, Chris Meesen, Bianca Lizrova Preiningerova, Jana Prugnaud, Jean-Louis Silva-Lima, Beatriz |
Appeared in: |
Multiple sclerosis |
Paging: |
Volume 22 (2016) nr. 2_suppl pages 47-59 |
Year: |
2016-08 |
Contents: |
|
Publisher: |
SAGE Publications, Sage UK: London, England |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|